SUMMARY, the calcium-sensitive fluorescent probe chlorotetracycline was used to monitor calcium movement in human platelets. The chlorotetracycline fluorescence signal is a linear measure of the level of free calcium in the dense tubules and in the mitochondria, with probe sensitivity in the millimolar range. Experiments perturbing the system with the calcium ionophore A23187 shows that the level of free internal calcium in the organelle depends upon the cytoplasmic level, which, in turn, depends upon the passive permeability of the plasma membrane. Chlorotetracycline in the cytoplasmic compartment does not respond to changes in the cytoplasmic calcium concentration, which is held in the micromolar to submicromolar range by an extrusion system. The calcium concentration in the cytoplasmic compartment can be directly manipulated by the calcium ionophore A23187 and is measured in parallel experiments with Quin 2, a highaffinity indicator. The calcium transport systems of the organelles are shown to be less susceptible to short circuit by A23187. Analysis shows that mitochondrial uptake is slow (ti/2 = 20 minutes), produces a large increase in chlorotetracycline fluorescence, and is inhibited by sodium azide plus oligomycin. Uptake by the dense tubules is more rapid (t]/ 2 = 2 minutes), produces a smaller increase in chlorotetracycline fluorescence, is inhibited by trifluoperazine, and is less sensitive to A23187. The K m is estimated as 1 /*M or lower. Studies show that the chlorotetracycline technique is useful for the monitoring of calcium uptake and release by the platelet organelles, and suggests that the Quin-2/chlorotetracycline technique will be useful as a diagnostic of both physiological and pathological activation mechanisms. (CircRes 55: 595-608, 1984) 
THE platelet plays a central role in the maintenance of the integrity of the vascular system. Exposure of the platelet to stimuli such as collagen, adenosine diphosphate (ADP), or thrombin results in a series of reactions leading to clot formation. Initial responses include the following: (1) a shape change which increases the surface area and provides a surface capable of adhering to the subendothelium, other platelets, and red blood cells (Frojmovic and Milton, 1982) , (2) the release of secretory granules containing ADP, serotonin, adenosine triphosphate (ATP), calcium (Ca ++ ), platelet factor 4, acid hydrolase, fibrinogen, etc. (Holmsen et al., 1969) , and (3) massive aggregation.
For platelets in the unactivated or resting state, the intracellular free Ca ++ concentration is maintained at the 10~7 M range ). An increase in cytoplasmic Ca ++ is sufficient to induce both the shape change and the release reaction (LeBreton et al., 1976; Feinstein, 1980; Knight and Scrutton, 1980; Lyons and Shaw, 1980) . The aggregation reaction requires both external membranebound Ca ++ (Hepstinstall 1976; Peerscheke et al., 1980; Taylor and Hepstinstall, 1980; Ganguly and Bradford, 1982) and increases in cytoplasmic Ca ++ (Massini and Luscher, 1976; Owen and LeBreton, 1980; Rink et al., 1982) . Stimulation elevates cytoplasmic Ca ++ concentrations, either by releasing Ca ++ from intracellular stores or by increasing Ca influx across the plasma membrane (Feinman and Detwiler, 1974; Massini and Luscher, 1974; White et al., 1974) . The sources of intracellular sequestered Ca ++ , and the regulation of its release and uptake are not well understood. Biochemical studies have identified and characterized an ATP-dependent Ca ++ uptake mechanism in human platelet membrane fractions (Robblee et al., 1973; Kaser-Glanzman et al., 1977; Fox et al., 1979; Javors et al., 1982) . A fraction of the membranes was purified and identified as the dense tubular system (Meriashi et al., 1981) and active uptake by this fraction was shown to be inhibited by trifluoperazine (TFP) . In this paper, we investigate intracellular Ca ++ sequestration in situ using fluorometric methods.
The Ca ++ -sensitive fluorescent probe chlorotetracycline (CTC)* has been applied widely in biological 
EXTERNAL MEDIUM
systems (Caswell and Hutchison, 1971; Caswell, 1972; Caswell and Warren, 1972; Williams, 1978a, 1978b; Gershergorn and Thaw, 1982) to monitor active Ca ++ transport. A large increase in fluorescence accompanies active Ca transport. Our previous work with isolated sarcoplasmic reticulum (SR) has shown that CTC fluorescence can be used to report the free internal Ca ++ concentration obtained by the Ca ++ ,Mg ++ -ATPase pump (Millman et al., 1980) . We have modeled the phenomenon showing that the fluorescence increase is proportional to the free internal Ca ++ concentration ([Ca ++ ]i) in the SR lumen. The mechanism is based on accumulation of the Ca-CTC complex in aqueous compartments having high Ca ++ concentrations and binding of the complex to the membrane to produce a large increase in CTC fluorescence. In the SR, the CTC response is detectable when the internal free Ca ++ concentration exceeds 1 X 10~4 M. Figure 1 shows the application of these principles to the platelet, with high levels of (Ca-CTC) + bound to the outer surface of the plasma membrane and on the inner surface of the organelle membranes. The former contribution is constant for constant external Ca ++ concentration ([Ca ++ ] o ). The latter contribution varies directly with Ca ++ uptake and release by the organelles. Figure 1 also shows that changes in the cytoplasmic Ca ++ concentrations are not reported by the technique, since the cytoplasmic free Ca ++ concentration is usually less than 10~6 M.
Further details are given in Methods, and in the references cited. This mechanism is implicit in earlier studies of Ca ++ handling using CTC fluorescence as a probe. LeBreton et al. (1976) interpreted decreases in CTC fluorescence as a release of Ca ++ from internal membrane compartments and correlated these with the platelet shape change. Feinstein (1980) also used the CTC technique to demonstrate that the release of intracellularly sequestered Ca ++ precedes the onset of stimulus-induced exocytosis.
The present communication extends these observations. By using the Ca ++ ionophore A23187 to increase the cytoplasmic free Ca ++ concentration, we show that net Ca ++ uptake (or release) by the organelles is easily followed by monitoring the CTC signal. We also show that the technique can be used to differentiate between Ca ++ accumulation by the mitochondria and by the dense tubular system, laying the groundwork for quantitative study of Ca ++ uptake and release with physiological activators. The present study will also develop experimental approaches which may be useful in pinpointing disorders in abnormal platelets.
Methods
Apyrase, A23187, oligomycin, EGTA, bovine serum albumin, antimycin A, 2-deoxyglucose, and heparin were purchased from Sigma. Other indicators and drugs were obtained as follows: chlorotetracycline, ICN Pharmaceuticals; Quin 2 AM, Lancaster Synthesis Ltd.; trifluoperazine, Smith, Kline & French; and NaN 3 , Alfa Products. The remaining reagents for Tyrode's solution were obtained from Mallinckrodt.
Washed Platelet Suspension
Freshly prepared platelet concentrate was purchased from a local commercial blood bank and was worked up and studied on the same day. The blood bank procedure was as follows: 250 ml of blood was drawn into ACD (acid-citrate-dextrose) collection bags, and the red cells were removed by centrifugation at 150 g for 15 minutes. The maximum time from blood drawing to receipt of the platelet concentrate was 3 hours. In our laboratory, the platelets were separated from the plasma by a centrifugation at 1100 g for 7 minutes in a clinical centrifuge (International, model CL). The platelets were washed twice and suspended in calcium and magnesium-free Tyrode's solution containing 138 mM NaCl, 3 mM KG, 5.5 mM glucose, 12 DIM NaHCO 3 , 0.4 mM NaH 2 PO 4 , with the pH adjusted to 7.35 with HC1 and checked on an hourly basis according to the method of Mustard et al. (1972) . This medium was used in all experimentation. The platelet concentration was adjusted to give 20% transmittance for aggregation experiments and 40% transmittance for CTC fluorescence experiments. This corresponded to 0.1 mg/ ml protein concentration. Quin 2 experiments were carried out at the same concentration of platelets as in CTC experiments. Storage was at room temperature and experimentation was at 37°C.
Fluorescence Measurements
Fluorescence was measured in a Perkin Elmer (model MPF-3L) fluorometer equipped with a thermostatically controlled cell holder (T = 37°C). Reactions were carried out in a 1-cm plastic cuvette. Mixing and stirring was achieved by a top-mounted motor-driven plastic stirring rod. The excitation beam was polarized horizontally by a single polarizer (Chen, 1966) to reduce the light-scattering effects to negligible values. The fluorometer collects emitted light over a wide angle, and control experiments showed that inner filter effects were negligible. Repetition of the fluorescence experiments at lower platelet concentrations (1/2 or 1/4 of the normal concentration) resulted in identical fluorescence amplitude ratios and kinetics. The absolute amplitudes are proportional to the platelet concentration. Independence of the amplitude ratios and kinetics on platelet concentration was observed both in experiments involving aggregation (A23187 addition) and in experiments where aggregation was not elicited. This, together with the lack of an inner filter effect, is good evidence that aggregation per se is not affecting our measurements.
Chlorotetracycline Fluorescence as a Quantitative Measure of [Ca

++
]i CTC fluorescence was measured at 380-nm excitation and 520-nm emission. Previous work with sarcoplasmic reticulum has shown that the probe reports the free internal Ca ++ concentration in the organelle lumen by the following mechanism: CTC can permeate in the neutral uncomplexed form and the internal and external CTC concentrations will be equal at equilibrium. The aqueous CTC° also exits as an anion (CTC") with a pK a of 6.8 for the transition (Millman et al., 1980) . Within the lumen, Ca ++ complexes with CTC to give a small increase in fluorescence:
.
(1) The complex can bind to the inner surface of the membrane with a large increase in fluorescence:
It is this species which makes the largest contribution to CTC fluorescence in the membrane-containing system. We have shown that when the membrane concentration is low enough to allow the bulk of the CTC to remain at constant concentration in the aqueous phase, the amount of (Ca-CTC)i!b is proportional to [ + bound to the outside surface of the plasma membrane. These relationships are shown schematically in Figure 1 . The contribution of (Ca-CTC) + bound to the outside surface of the platelet can easily be determined, since it occurs instantaneously upon addition of CTC or upon the addition of Ca ++ in the presence of CTC (cf. Fig. 2 ). The organelle contribution occurs with a ti/2 of 4 ~ 5 minutes due to the necessity of CTC permeation across the membranes. The Results section shows that, under most conditions, the cytoplasmic Ca ++ concentration is held in the less-than-micromolar range. Thus, there is little contribution from cytoplasmic (Ca-CTC) + or from the cytoplasmically oriented ("p faces') of the platelet membranes. CTC is also able to make complexes with endogenous Mg ++ (cf. Caswell and Hutchison, 1971; Caswell, 1972; Caswell and Warren, 1972) . These make a constant contribution to the CTC signal, since the internal Mg ++ concentration does not vary. Their contributions can be shown to be small by comparison of experiments with and without metabolic inhibition. The affinity of CTC for Ca ++ is also dependent on pH. Internal alkalinization produces a higher affinity, which results in increased fluorescence at constant [Ca ++ ]i. Experiments with Tris, a penetrating buffer which reduces pH gradients across membranes (Haynes, 1982) , suggest that our results are not influenced by this factor.
Quin 2 Experiments
Free cytoplasmic calcium concentrations were measured by the Quin 2 method. Quin 2 AM loading of the platelets was accomplished using the procedure of Rink et al. (1982) . The platelets were washed until the internally trapped Quin 2 represented over 99% of the cell-associated indicator. Control experiments showed that Quin did not leak from the platelets during the course of the experiment. Quin 2 fluorescence was recorded at 340 nm (excitation) and 490 nm (emission). The free internal calcium concentrations were calculated from the extent of Ca ++ complexation of the Quin 2 and from the published values of the equilibrium constant of the reaction [K<j = 115 riM ]. The extent of Quin 2 complexation with Ca ++ is determined readily from comparison of the sample fluorescence with the fluorescence observed in the Ca ++ -saturated and Ca ++ -free medium. In our experiments, the latter two quantities were determined in situ by Ca ++ -saturation and Ca ++ -depletion (excess EGTA). Ca ++ permeability was facilitated by digitonin. Calibrations were carried out for every platelet sample studied. 
Platelet Aggregation Measurement
The platelet aggregation was measured by the turbidimetric method (Born, 1962) . The extent of platelet aggregation was determined by monitoring transmittance change in a Beckman spectrophotometer (model DB-G) at 600 nm. This instrument was also equipped with a plastic cuvette and motor-driven stirring rod.
Control of Extracellular Ca ++ Concentration
Activation experiments were carried out at several external Ca ++ concentrations. In the range of 0.1 to 20 mM, the calcium concentration was set by simple Ca ++ addition. In the range of 10" 4 to 10" 8 M, the Ca ++ concentration was controlled by a Ca ++ -EGTA buffer ([EGTA], = 2 mM). The Ca ++ :EGTA ratio was set, and the free Ca ++ concentration was calculated using the published equilibrium constants (Martell and Smith 1974; cf. Haynes and Mandveno, 1983) .
Quality Control and Reproducibility
The quality of the platelet sample was determined routinely before experimentation. No spontaneous aggregation was found upon stirring. All samples had to show normal aggregation kinetics. The ED 50 for collagen and ADP-induced aggregation was 15-25 /ig/ml and 1-3 /m, respectively. This compares with literature values of 30 /ig/ml (Chesney et al., 1972) and 3 HM (MacMillan, 1966) , respectively. Occasional samples that did not meet these criteria or that showed abnormal rates or extents of reaction were discarded. The CTC assay itself was also used as a criterion of quality. The responses shown in Figure 2 were observed to be more sensitive measures of platelet quality than the above-cited tests. After approximately 24 hours of storage, the slow amplitudes shown in Figure 2 would increase, while the size of the response to A23187 would decrease. This pattern was also observed in our testing of platelets from patients suffering from arterial or venous thrombosis. In the present study, all of the samples were from normal donors, all had passed the abovementioned criteria, and all were studied in the first 24 hours after blood drawing.
All of the phenomena reported here were observed at least three times with three separate preparations. 
Results
CTC as a Measure of Ca ++ Homeostasis
Figure 2 is a typical experiment showing that platelet-associated CTC responds to changes in Ca ++ . Curve A shows the results of serial addition of platelets, CTC and Ca ++ . The platelet addition gives rise to only a small light-scattering artifact. Addition of CTC results in a rapid rise in fluorescence, followed by a slow increase with a ti /2 of 4-5 minutes. The rapid change is due to the fluorescence of CTC in the aqueous phase and CTC bound to the outer surface of the plasma membrane. At the low ambient external Ca ++ concentration, the corresponding Ca ++ complexes make only a small contribution (cf. Fig. 1 ). The slow fluorescence increase will be shown to arise primarily in the binding of CTC and its Ca ++ complexes to the inner surfaces of the organelles. The control experiments (curve C) in the absence of platelets show that only 20-25% of the rapid response is due to CTC in the aqueous phase. No slow phase was observed. Information about Ca ++ handling by the platelets is obtained by observing the response to Ca ++ addition. Curve A shows that the addition of Ca ++ to a final concentration of 2 mM gives rise to two phases of increase: (1) an instantaneous phase corresponding to the binding of the (Ca-CTC) + complex on the outside surface, and (2) a slower phase (ti/ 2 = 6-8 minutes) due to increases in internal Ca ++ , which, in turn, give rise to increased (Ca-CTC) + binding to the internal membranes. The slow phase amplitude is 11 units. Addition of EGTA to reduce the free external Ca ++ concentration to the 10~8 M range returns the fluorescence signal to its pre-Ca ++ levels. The reversal also occurs in a biphasic manner. Comparison with curve B shows that the slow phase amplitude can be blocked by inhibitors of energy metabolism in Ca ++ transport. The platelet sample of curve B was pretreated with NaN 3 , oligomycin, and trifluoperazine (TFP) for 1 hour and the procedure of curve A was repeated. The comparison shows that pretreatment with metabolic inhibitors lowers the amplitudes and shortens the half-times of the slow phases observed in both the CTC and Ca ++ jumps. The fast phase amplitudes were not affected. Such behavior would be expected if the slow phase amplitude of curve A depended on actively accumulated Ca ++ in the organelles. Furthermore, the lack of effect of inhibitors on the fast phases is also in line with our interpretation; metabolic inhibitors would not be expected to affect the plasma membrane surface area or CTC affinity. The lack of effect of inhibitors on the amplitudes assigned to the outside surface is readily seen by comparison of the fast amplitudes of curve A and B.
Influence of A23187
Further experimentation was carried out to demonstrate that the CTC signal indicates the free Ca ++ concentrations in two or more intracellular compartments, and that each of these is, in turn, influenced by the extracellular Ca ++ concentrations. Figure 3 shows the CTC response of metabolically competent platelets to elevation of cytoplasmic Ca ++ concentrations brought about by addition of the Ca ++ ionophore A23187. The platelets were preincubated with 2 mM Ca ++ and 10 / XM CTC to reach the state identical to the plateau phase in Figure 2 . Next, 2.5 HM A23187 was added. The figure shows that ionophore addition in the presence of 2 mM Ca ++ brings about an increase in fluorescence of 23 units resulting from influx of Ca ++ and uptake by the organelles. In contrast, Ca ++ addition in the absence of ionophore (Figure 2 ) results in no aggregation and a much smaller fluorescence increase (11 units for the slow phase). The increase in plasma membrane Ca ++ permeability is sufficient to explain this difference. The ionophore-induced fluorescence increase occurs in two phases, a fast phase with a ti/2 of 2 minutes, and a slower phase with a ti/ 2 of 20 minutes. The slow phase is complete in 60 minutes. Both of these phases are slower than the exocytotic release events which occur in the first 5-10 seconds after activation with ionophores (Feinstein, 1980) . The next section will show that the A23187-elicited increases in CTC fluorescence are sensitive to metabolic inhibition. The results observed in Figure 2 and 3 are in accord with the well-accepted role of the plasma membrane as a regulator of the cytoplasmic Ca ++ concentration and the established ability of intracellular organelles to accumulate Ca ++ actively from the cytoplasmic pool. Stochastic analysis shows that the balance between the pumping activity of the plasma membrane and organelle membranes which accumulate Ca ++ from the cytoplasm is expected to be an important determinant of the platelet-associated Ca ++ . The levels of organelle-associated Ca ++ are moderately sensitive to the external Ca ++ concentration under normal conditions (Figure 2 ). The balance is shifted in favor of the organelles when the plasma membrane is made Ca ++ permeable by A23187. This is supported by experiments described in a later section, in which the plasma membrane is made leaky by treatment with digitonin. The two phases of organelle-associated CTC fluorescence change and Ca ++ uptake are separated through the use of metabolic inhibitors, as discussed in the next section.
Influence of Metabolic Inhibitors
The protocol of Figure 3 was repeated with platelets incubated with several metabolic inhibitors. Figure 4 shows that two organelle systems can be identified on the basis of sensitivity to the inhibitors. Curve A is identical to the experiment of Figure 3 (no inhibitors). The figure shows that NaN 3/ an inhibitor of mitochondrial electron transport, inhibits 60 ± 3% (mean ± SE, n = 4) of the response (curve D). An identical effect was observed with 10 fiM antimycin A (56 ± 4% inhibition; data not shown). No additional effect was observed when azide and antimycin was added together. Azide and antimycin A have been shown to inhibit mitochondrial electron transport (Stannard and Horecker, 1948; Lardy and Ferguson, 1969) and are adequate to inhibit electron transport-dependent mitochondrial Ca ++ uptake (Brierley, 1963; Lehninger et 1967; Mela, 1977; Luthra and Olson, 1978; Nicholis and Akerman, 1982) , and have been used for this purpose in platelets (Muerer et al., 1967; Mills, 1973) . Also, control experiments in which the inhibitor concentrations were varied showed that this represents complete inhibition of the mitochondrial contribution to the Ca ++ uptake-associated CTC signal. Oligomycin has been shown to inhibit mitochondrial use of ATP to support ion transport (Moore and Pressman, 1964; Kagawa and Racker, 1966; cf. Cockrell et al., 1966) and has also seen application in platelets (Muerer et al., 1967; Mills, 1973) . Application of oligomycin + azide (curve D) does not produce significantly greater inhibition than azide alone (curve D). Since azide + oligomycin blocks both mitochondrial energy production and mitochondrial use of ATP, the difference between the control and azide + oligomycin curves must represent the uptake characteristics of the mitochondria. The difference representing the mitochondrial contribution is characterized by a slow uptake (ti/ 2 = 20 minutes) and a large extent of fluorescence increase.
Trifluoperazine (TFP) has been shown to inhibit ATP-energized Ca ++ uptake in the isolated dense tubular system (White et al., 1982) . Figure 4 shows that 15 fitA TFP produces a substantial inhibition (27% ± 4%; mean ± SE, n = 4) of the CTC fluorescence associated with Ca ++ uptake. Additional experiments (not shown) established 15 /iM as the concentration giving optimal effect.f The difference between the control and the TFP curves gives the uptake characteristics of the TFP-inhibitable dense tubular Ca ++ uptake system. The system is characterized by a rapid uptake (ti/ 2 ~ 2 minutes) and a small extent of fluorescence increase.
The lowest curve in Figure 4 represents the CTC fluorescence change observed in the presence of NaN 3 , oligomycin, and trifluoperazine (mitochondrial and dense tubular inhibition). This residual corresponds to the (Ca-CTC) + associated with the cytoplasmic pool and uptake by any remaining organelles which are not influenced by this system. The latter includes storage granules.:}: X Storage granules contain a high concentration ofCa** and ATP. However much of the Ca** is thought to exist as an ADP, ATP, or 5-hydroxytryptamine complex which would not contribute to Ca-CTC An important test for the correctness of our analysis can be made by comparison of amplitudes of the curves in Figure 4 . If the mitochondrial and dense tubular inhibitors work only on their respective organelles, then the effects of the inhibitors should be additive. Figure 4 shows that this expectation is fulfilled, since curve A = curve C + curve E -curve F. This indicates that the dense tubular and mitochondrial uptakes occur independently of one another and do not compete for metabolic energy under the conditions of the experiments. The experiments clearly identify the rapid phase of uptake (ti/2 = 2 minutes) with the dense tubular system and the slower phase with the mitochondrial system.
Sources of Energy for Mitochondrial and Dense Tubular Uptake
With the dense tubular and mitochondrial uptake differentiated on the basis of TFP and NaN 3 + oligomycin, respectively, we can make further deductions about the source of energy for uptake by the two organelles. Oligomycin can block both ATP production and usage by the mitochondria. As noted above, oligomycin alone shows little inhibition of uptake (curve B vs. curve A). This shows that the dense tubules do not require ATP produced by oxidative phosphorylation. Comparison of curves D and E shows that the mitochondria cannot use energy generated by glycolysis to take up Ca ++ . Curve E (NaN 3 + oligomycin) and the above-mentioned additivity relationships demonstrate that glycolysis is sufficient to drive dense-tubular Ca ++ uptake. To test the effect of inhibition of glycolysis, platelets were preincubated with 30 rrtM 2-deoxyglucose. Experiments (not shown) revealed no effect of this preincubation on the CTC response observed after A23187 addition. However, preincubation with 2-deoxyglucose plus azide or antimycin A for 1 hour totally inhibited the CTC response to A23187. The comparison shows that when energy production by glycolysis is largely inhibited, oxidative phosphorylation is still able to provide sufficient energy to meet both the demands of resting Ca ++ homeostasis and complex formation on the membrane surface. The bulk of the Ca** is stored in an inert form, and is not thought to equilibrate rapidly with the cytoplasm. The upper limit of the fluorescence contribution of Ca** and Ca-ADP from the storage granules is given in the lowest curve of Figure 4 . It has been suggested to us that A23187 might liberate Mg** from the cells and make a negative contribution to CTC fluorescence. Curve F shows this is not the case. Another possible source of artifact could arise from exocytosis which results in expulsion of the vesicle and vesicle contents. It is conceivable that this reaction could increase the exposed surface of the outer plasma membrane to such an extent as to affect the CTC signal (ca. 10% of instantaneous phase of Figure 2 ). This would be expected to contribute not more than two fluorescence units. Comparison of the instantaneous amplitudes observed upon Ca** addition before activation and observed with Ca** removal after activation shows that the two are identical, and no such contribution is detected. Also, the exocytotic events occur in the first 5 seconds to 3 minutes (ti/i = 20-25 seconds) after activation (Detwiler and Feinman, 1973) , whereas the increases in Ca** uptake occur on the time scale of 2-20 minutes. Figure 5 , curve A, shows the dependence of the amplitude of the A23187-induced organelle uptake reactions on the external Ca ++ concentration for metabolically competent platelets. The phenomenon encompasses both dense tubular and mitochondrial uptake. The next section will give evidence that at the A23187 concentration chosen (2.5 /XM) the Ca ++ expulsion mechanism of the plasma membrane has been seriously compromised, while the Ca ++ accumulation mechanisms of the dense tubules and mitochondria are relatively unaffected. Figure 5, , the A23187-induced increase was also largely abolished. The low amplitudes of curve B are expected, since the experiment of the previous figure shows that active uptake by the organelles is blocked by this combination of inhibitors. We consider the greatly diminished amplitudes plotted in curve B to be representative of equilibrium of the stated Ca ++ concentrations with the cytoplasmic compartment and with the lumena of the dense tubules, mitochondria, and other membraneous structures. The difference between curves A and B of Figure 5 represents active transport of Ca ++ into the dense tubules and mitochondria.
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A23187 Concentration Dependence of Calcium
Uptake by Organelles Figure 6 shows the A23187 concentration dependence of the Ca ++ uptake by the organelles at a constant external Ca ++ concentration of 2 mM. The figure shows that at a low A23187 concentration, the extent of Ca ++ uptake increases with increasing A23187 concentration. This is expected if the steady state level in the cytoplasm increases with increasing rate of A23187-induced leakage rate. Increases in the cytoplasmic Ca ++ concentration would, in turn, increase the levels of organelle-sequestered Ca ++ . The observation of maximal uptake at 20 HM A23187, and the decline of active accumulation at A23187 concentrations above this value, can be readily explained in terms of this model. At higher A23187 levels, the passive Ca ++ permeabilities of Circulation Research/Vol. 55, No. 5, November 1984 the organelle membranes become comparable to the rates of their correponding active Ca ++ uptake systems, and their ability to accumulate Ca ++ decreases. Curve B shows that after treatment with NaN 3 , oligomycin, and TFP, the fluorescence increase is smaller. It reaches a plateau at 15 /*M A23187, a concentration which is adequate to short-circuit the plasma membrane and any accumulation of systems which might be unaffected by our inhibitors. The data obtained under inhibition at high A23187 concentration may provide a basis for quantification of the active uptakes.
Our interpretations of the ionophore effect are supported by experiments in which the plasma membrane was made leaky by other means. An extensive study with rat hepatocytes (Murphy et al., 1980) showed that digitonin can make the plasma membrane leaky to Ca ++ without disrupting the membranes of the organelles. The selectivity was derived from the specificity of digitonin for cholesterol and from the high mole fraction of cholesterol in the plasma membrane. Using the hepatocyte experimentation as an example, we treated platelets (0.1 mg/ml) with digitonin (1 ng/n\l) and observed the CTC fluorescence response. Addition of 1 X 10~7 to 1 X 10~5 M Ca ++ gave rise to an ATP-dependent increase of CTC fluorescence responses similar to those observed upon the addition of A23187 (data not shown). The fluorescence increase observed with Ca ++ addition was similar to that shown in Figure 3 for ionophore addition, except that the response was somewhat larger and more rapid. This is what is expected for selective or semi-selective permeabilization of the plasma membrane. Thus, our results with digitonin seem to reinforce our interpretation of the effects of A23187. More extensive manipulation of the cytoplasm of the platelet will be described in a future publication.
Dependence of Organelle Uptake Reactions on [C + + ]
The Quin 2 technique was used to obtain information about the free cytoplasmic Ca ++ concentration achieved in the manipulation described above. Our initial experiments, carried out as described in Methods, showed that the resting level of Ca ++ was around 100-130 nM, in agreement with the results of Rink et al. (1982) . Upon addition of high concentrations of A23187 with millimolar external Ca ++ concentrations, the dye indicated cytoplasmic levels of greater than 2 ^M. This shows that the cytoplasmic Ca ++ concentration can be radically influenced by the ionophore, given an adequate external Ca ++ concentration. In further quantitative studies of this effect (Fig. 7) , conditions had to be chosen which would perturb the cytoplasmic Ca ++ concentration within the working range of the dye (0.1-2 HM). In the experiments described in Figure 7 , a small concentration of A23187 (0.5 HM) was chosen in order to produce a large effect on the Figure 7A shows the CTC response achieved after A23187 addition at several external Ca ++ concentrations. In parallel, the level of cytoplasmic free calcium was monitored with Quin 2 (Fig. 7B) . The CTC response was either an increase or decrease in fluorescence, depending on the external Ca ++ concentration. At high [Ca ++ ] o , the organelle-associated CTC fluorescence increases after a lag. At low external Ca ++ levels, a decrease is observed. At intermediate levels, Ca ++ release is observed, followed by reuptake. In all of the parallel Quin 2 experiments, the A23187 addition was observed to in- ]cy t . The phenomenon of overshoot and subsequent decrease is interpreted as massive Ca ++ influx from the external medium and subsequent uptake by the organelles. Figure 7 showed that upon addition of 0.5 /*M A23187 in the presence of external Ca ++ concentrations in the intermediate range (5 X 10" 7 to 0.25 mM), and initial decrease in CTC fluorescence is observed. This is followed by an increase representing reuptake of Ca ++ . This suggests release by one organelle and uptake by the other. The experiment shown in Figure 8 tests the inhibitor sensitivity of the reuptake phenomenon under identical conditions, and shows that the reuptake is due to the dense tubules. The platelets were preincubated with 5 X 10" 5 M Ca ++ , and the release phase was initiated by adding 0.5 HM A23187. In the middle of the reuptake phase, NaN 3 and oligomycin were added (curve A) to inhibit the mitochondrial contribution. Only slight attenuation of the rate was observed, showing that the mitochondria were not contributing to the reuptake phase. Next, the reuptake was challenged with TFP, the inhibitor of dense Ca ++ uptake. Curve A shows that the reuptake process was immediatly reversed and inhibited. Panel B shows the effect of the inverse order of addition. Reuptake is promptly reversed and inhibited by TFP addition; mitochondrial inhibition produces little additional effect. We conclude from this that, at low values of [Ca ++ ] o and [Ca ++ ] cyt (5 X 10" 5 and 5 X 10~7 M, respectively), 0.5 fiM A23187 short-circuits the mitochondrial system but has little effect on the dense tubular system. This correlates with observations of low rates of mitochondrial Ca ++ uptake and high rates by the dense tubular system.
The information contained in ]cy t ) is dominated by the dense tubular contribution. Thus, the rates of the uptake seen in Figure 7 are characteristic of the dense tubular system. Figure 9 shows the dependence of the initial rate of uptake on [Ca ++ ] cy t . These quantities are taken directly from Figures 7, A and B, respectively. The plot shows the saturation characteritics of the dense tubular system in situ. It shows that the rate increases from approximately 7% to 70% of its maximal value (shown by the dotted line) when [Ca ++ ]cyt is increased between 0.2 and 2 AIM. Half-maximal rates are observed at approx. 1 fiM. This agrees with an apparent K m of 0.5-1 /iM determined for isolated dense tubules (Robblee et al., 1973; Kaser-Glanzman et al., 1977) . The line through the points was fitted according to a second-power dependence of the rate on
Discussion
The most important contribution made in the present study is the development of methods by which Ca ++ movements in the human platelet can be observed rapidly and continuously. The technique depends on our observations that CTC fluorescence is a linear measure of [Ca ++ ]j in the dense tubules and mitochondria and makes use of Quin 2 as a cytoplasmic indicator. The characteristics of the Ca ++ handling systems of the platelet were probed by the Ca ++ ionophore A23187. The Ca ++ extrusion mechanisms of the plasma membrane are easily short-circuited by low concentrations of A23187, resulting in higher [Ca ++ ] cyt and net accumulation by the organelles. The Ca ++ uptake function of the organelles is less sensitive, and requires higher A23187 concentrations for attenuation. With the help of metabolic inhibitors, the two types of uptake were analyzed. Mitochondrial Ca ++ uptake is slow and results in large increases in fluorescence. Dense tubular Ca ++ uptake is rapid and results in a smaller increase in fluorescence. We have shown that oxidative phosphorylation can provide sufficient energy to power both types of uptake; that glycolysis can provide sufficient energy to power dense tubular uptake, and that energy produced by glycolysis cannot be used to power mitochondrial uptake. The implications of our methodology and findings will be discussed below under their respective headings.
CTC Fluorescence is a Linear Measure of [Ca
++ ]i in the Dense Tubules and the Mitochondria
Our experiments show that the fluorescence increase of CTC serves as an indicator of active accumulation of Ca ++ by the organelles of the platelet. Our previous experiments have shown that it is an indicator of the free Ca ++ concentration contained within the lumen of organelles (Millman et al., 1980 ; Dixon and Haynes, submitted for publication). The neutral form of CTC crosses membrane, eventually achieving equality of concentrations on both sides. The (Ca-CTC) + complex does not cross membranes, and thus accumulates in compartments with high internal free Ca ++ concentration. The mechanism of Figure 1 has been supported by mathematical analysis (Millman et al., 1980) , experiment (Dixon and Haynes, submitted for publication), and by the results of the present study. According to the mechanism, the concentration of (Ca-CTC) + complex bound to the membrane is proportional to the (Ca-CTC) + concentration in the aqueous phase. The former is proportional to the fluorescence increase observed; the latter is proportional to the free Ca ++ concentration (e.g., calcium activity) in that compartment. The fluorescence increase is thus proportional to the free Ca ++ concentration. We believe that it may be possible to make use of the surface area and volume relationships of the organelles to quantify the free internal Ca ++ concentration in the dense tubules and the mitochondria, using the CTC technique. From our data in Figure 5, Rossi et al. (1963) showed that large amounts of Ca ++ and phosphate can be taken up by mitochondria in a co-precipitation mechanism. The inner membrane contains large amounts of cardiolipids (Lehninger, 1964) Our study using the combined methods of CTC and Quin 2 fluorescence has produced a number of observations about Ca ++ handling by the intact platelet. Cytoplasmic levels are kept low (100-130 run) Fig. 7B, (Fig. 2) . Although it is perhaps intuitively obvious that this should be the case, our study is the first to demonstrate this. In a separate study, we have used the CTC technique to show that platelets from patients suffering from thrombosis have higher resting levels of Ca ++ in their dense tubules. The platelets also showed a greater amount of releasable Ca ++ than normal controls. Both the Ca ++ handling abnormality and the disease were reversed by medication with nifedipine . The success of both the CTC technique in detecting this abnormality and the drug in treating this hyperaggregable' condition seems to be based on the direct coupling of sequestered and cytoplasmic Ca ++ levels. Our study has differentiated between the mitochondrial and dense tubular contributions of Ca ++ uptake which occurs when [Ca ++ ] cy , is elevated by ionophore addition. The mitochondrial uptake is of large capacity as judged by the CTC signal. It is slow and is 90% inhibited by NaN 3 and 100% inhibited by NaN 3 plus oligomycin. In keeping with its lower rate, it is more susceptible to the action of ionophores than are the dense tubules. The uptake by the dense tubules is smaller, as judged by CTC, but is more rapid. It is inhibited by TFP (White et al., 1980) . Since the dense tubular uptake is more rapid, it is less susceptible to short-circuit by ionophores than is the mitochondrial uptake (Figure 8 ). We stress that the foregoing observations relate to the role of the organelles in reducing cytoplasmic Ca ++ concentration. In our A23187 experiments, the ionophore addition caused the platelets to aggregate. This is the direct result of Ca ++ influx to raise [Ca^cy,. With true physiological mechanisms, [Ca ++ ]cy t is elevated by influx, by dense tubular release, or by a combination of both. The dense tubular uptake occurring during A23187-induced aggregation is not part of the physiological activation mechanism. On the contrary, it is a manifestation of the normal homeostatic mechanisms which attempt to reduce [Ca ++ ]cy t to a quiescent level and to guard against spurious activation through random events.
Cytoplasmic
Circulation Research/Vol. 55, No. 5, November 1984 Our findings on the energetics of the Ca ++ removal system can be given a similar interpretation. Our finding that glycolysis can produce sufficient energy to maintain normal Ca ++ homeostasis for at least 30 minutes and to support active uptake by the dense tubules upon Ca ++ influx into the cell is significant. This finding is not surprising, since it would be undesirable for hemostasis and local ischemia to activate aggregation. A similar interpretation can be given to our finding that oxidative phosphorylation can power both mitochondrial uptake and dense tubular uptake, whereas glycolysis can power only dense tubular uptake. Under conditions of adequate energization it is expeditious to use all means at hand to lower [Ca ++ ]cy t ; under conditions of energy dearth, it is prudent to supply only the most rapid, efficient, and specific Ca ++ removal system. Seen in this context, the mitochondrion would seem to be a secondary line of defense against super-micromolar cytoplasmic Ca ++ concentrations.
Another implication of our study is that deficiencies in energy metabolism can raise [Ca ++ ]cy t and [Ca ++ ]j and thus predispose platelets to triggering of the aggregation response. As noted above, the CTC technique represents a most convenient means of investigating such relationships. The CTC plus Quin 2 technique is a diagnostic for both physiological and abnormal activation mechanisms.
Utility of the Method
Our method has resolved the kinetics of uptake and release from the mitochondria and dense tubules. It has also proven capable of monitoring the release from one pool and the uptake by the other ( Figure 7A ). This capability, together with the Quin 2 method, represents a powerful method of real time analysis of the Ca ++ handling systems in platelets. As an example of diagnosis of physiological mechanisms, quantitative comparisons of Figure 7, A and B, 
